Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Mar:165:105380.
doi: 10.1016/j.phrs.2020.105380. Epub 2020 Dec 16.

Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy

Elisa Borghi  1 , Valentina Massa  1 , Daniela Carmagnola  1 , Claudia Dellavia  1 , Chiara Parodi  1 , Emerenziana Ottaviano  1 , Arianna Sangiorgio  1 , Lucia Barcellini  1 , Greta Gambacorta  1 , Federica Forlanini  1 , Gian Vincenzo Zuccotti  2 ; UNIMI SAL Study group  1
Affiliations
Comment

Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy

Elisa Borghi et al. Pharmacol Res. 2021 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All the authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
SARS-CoV-2 RNA detection concordance tables for adult cohort (A), asymptomatic subjects (B), and children (C). Cycle Threshold (Ct) Values for 55 matched NPS and saliva positive samples (D), and linear regression for Pearson’s r (E).
See this image and copyright information in PMC

Comment on

  • Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2.
    Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL, Geng B, Muenker MC, Moore AJ, Vogels CBF, Petrone ME, Ott IM, Lu P, Venkataraman A, Lu-Culligan A, Klein J, Earnest R, Simonov M, Datta R, Handoko R, Naushad N, Sewanan LR, Valdez J, White EB, Lapidus S, Kalinich CC, Jiang X, Kim DJ, Kudo E, Linehan M, Mao T, Moriyama M, Oh JE, Park A, Silva J, Song E, Takahashi T, Taura M, Weizman OE, Wong P, Yang Y, Bermejo S, Odio CD, Omer SB, Dela Cruz CS, Farhadian S, Martinello RA, Iwasaki A, Grubaugh ND, Ko AI. Wyllie AL, et al. N Engl J Med. 2020 Sep 24;383(13):1283-1286. doi: 10.1056/NEJMc2016359. Epub 2020 Aug 28. N Engl J Med. 2020. PMID: 32857487 Free PMC article. No abstract available.

References

    1. Paltiel A.D., Zheng A., Walensky R.P. Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States. JAMA Netw. Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.16818. e2016818. - DOI - PMC - PubMed
    1. Wyllie A.L., Fournier J., Casanovas-Massana A., Campbell M., Tokuyama M., Vijayakumar P., Warren J.L., Geng B., Muenker M.C., Moore A.J., Vogels C.B.F., Petrone M.E., Ott I.M., Lu P., Venkataraman A., Lu-Culligan A., Klein J., Earnest R., Simonov M., Datta R., Handoko R., Naushad N., Sewanan L.R., Valdez J., White E.B., Lapidus S., Kalinich C.C., Jiang X., Kim D.J., Kudo E., Linehan M., Mao T., Moriyama M., Oh J.E., Park A., Silva J., Song E., Takahashi T., Taura M., Weizman O.-E., Wong P., Yang Y., Bermejo S., Odio C.D., Omer S.B., Dela Cruz C.S., Farhadian S., Martinello R.A., Iwasaki A., Grubaugh N.D., Ko A.I. Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2. N. Engl. J. Med. 2020;383:1283–1286. doi: 10.1056/NEJMc2016359. - DOI - PMC - PubMed
    1. Vogels C.B.F., Watkins A.E., Harden C.A., Brackney D., Shafer J., Wang J., Caraballo C., Kalinich C.C., Ott I., Fauver J.R., Kudo E., Lu P., Venkataraman A., Tokuyama M., Moore A.J., Muenker M.C., Casanovas-Massana A., Fournier J., Bermejo S., Campbell M., Datta R., Nelson A., Team Y.I.R., Dela Cruz C., Ko A., Iwasaki A., Krumholz H.M., Matheus J., Hui P., Liu C., Farhadian S., Sikka R., Wyllie A.L., Grubaugh N. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. MedRxiv. 2020 doi: 10.1101/2020.08.03.20167791. 2020.08.03.20167791. - DOI - PMC - PubMed
    1. Yokota I., Shane P.Y., Okada K., Unoki Y., Yang Y., Inao T., Sakamaki K., Iwasaki S., Hayasaka K., Sugita J., Nishida M., Fujisawa S., Teshima T. Mass screening of asymptomatic persons for SARS-CoV-2 using saliva. Clin. Infect. Dis. 2020 doi: 10.1093/cid/ciaa1388. - DOI - PMC - PubMed
    1. Iwasaki S., Fujisawa S., Nakakubo S., Kamada K., Yamashita Y., Fukumoto T., Sato K., Oguri S., Taki K., Senjo H., Sugita J., Hayasaka K., Konno S., Nishida M., Teshima T. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva. J. Infect. 2020;81 doi: 10.1016/j.jinf.2020.05.071. e145–e147. - DOI - PMC - PubMed